HPLC분석관련
COVID-19관련 논문 및 YMC 대응 Column
COVID-19관련 연구에서 사용한 YMC 컬럼의 종류와 관련 Reference입니다.
주요 분석 물질 | 게재 논문명 | 사용 추천 Column | Reference |
Fluoxetine | Simultaneous Determination of Olanzapine and Fluoxetine by HPLC |
(TA12S05-1546PTH) |
B. V. Reddy et al., Chromatographia 66 (2007) 111-114. |
Dexamethasone | Development and validation of HPLC method for analysis of dexamethasone acetate in microemulsions |
(TA12S05-2546PTH) |
2009) 87-92. |
Dexamethasone | Dexamethasone Monograph | Ph. Eur. 7 (2010) | |
Ritonavir | United States Patent: Ritonavir Bis-Hydrochloride |
(BU12S03-1546WT) |
M. Acquasaliente et al. United States Patent, Patent No. US 8.598.216 B1 (2013). |
Ritonavir | Development and Validation of a Simple, Sensitive, Selective and Stability-Indicating RP-UPLC Method for the Quantitative Determination of Ritonavir and Its Related Compounds |
(TA12SP9-10Q1PT) |
S. Koppala et al., Journal of Chromatographic Science, 53 (2015) 662–675. |
Ritonavir | Ritonavir Monograph |
(BS12S03-1546WT) |
Ph. Eur. 8 (2014) |
Lopinavir | Lopinavir Monograph | YMC-Triart C18 (TA12S03-2546PTH) | Ph. Eur. 8 (2014) |
Ritonavir, Lopinavir | RP-HPLC method for simultaneous estimation of antiretroviral drugs lopinavir and ritonavir in table dosage form |
(TA12S05-2546PTH) |
I. Ponnilavarasan et al., Digest Journal of Nanomaterials and Biostructures Vol. 5, 3 (2010) 771-778. |
Fenofibrate | Phase separation of supersaturated solution created from amorphous solid dispersions: Relevance to oral absorption |
Jsphere ODS-H80 (JH08S04-L546WT) |
K. Kawakamia et al., European Journal of Pharmaceutics and Biopharmaceutics, 132 (2018) 146–156. |
Interferon alpha-2 |
Study of aggregation, denaturation and reduction of interferon alpha-2 products by size-exclusion high-performance liquid chromatography with fluorescence detection and biological assays |
YMC-SEC MAB(DLM25S05-3008WT) YMC-Pack Diol-120(DL12S05-3008WT) |
A. Diress et al., Journal of Chromatography A, 1217 (2010) 3297–3306. |
Chloroquine | Identification of Falsified Chloroquine Tablets in Africa at the Time of the COVID-19 Pandemic |
(TA12S05-2504PTH) +YMC-Triart C18(TA12S05-1546PTH) |
G. Gnegel et al., American Journal of Tropical Medicine and Hygiene, 00 (2020) 1–4. |
Chloroquine | In vitro Metabolic Stability Study of New Cyclen Based Antimalarial Drug Leads Using RP-HPLC and LC-MS/MS | YMC-Triart C18(TA12S05-1546PTH) +YMC-Triart C18(TA12S05-2546PTH) | A. V. Rudraraju et al., Modern Chemistry & Applications, 2 (2014) 129. |
Fingolimod | Absorption and Disposition of the Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) in Healthy Volunteers: A Case of Xenobiotic Biotransformation Following Endogenous Metabolic Pathways |
(TO12S03-0546PTH) |
M. Zollinger et al., Drug Metabolism and Disposition, 39:2 (2011) 199-207. |
Pirfenidone | Development and Substantiation of a RP-HPLC Method for Monitoring of Impurities in Pirfenidone Drug Substance |
(TA12S05-2546PTH) |
S. B. Bodempudi et al., American Journal of Analytical Chemistry, 6 (2015) 1019-1029. |